Belite Bio (BLTE) Other financing activities (2023 - 2025)
Belite Bio (BLTE) posted quarterly Other financing activities of $1.4 million for Q4 2025, down 95.18% year-over-year from $28.8 million in Q4 2024, and down 95.18% quarter-over-quarter from $28.8 million in Q4 2024.
Belite Bio (BLTE) Other financing activities (2023 - 2025) Analysis & Trends
Belite Bio's Other financing activities history runs 3 years deep, the most recent figure standing at $1.4 million for Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Belite Bio | 6.40 Bn | 6.40 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.39 Mn |
| Dec 31, 2025 | 1.39 Mn |
| Dec 31, 2024 | 28.75 Mn |
| Dec 31, 2024 | 28.75 Mn |
| Dec 31, 2023 | 21.65 Mn |
| Dec 31, 2023 | 21.65 Mn |